NEWS 96 FEED & ADDITIVE MAGAZINE August 2024 Adam Banaszak joined Novus as Director of Global Channel Management. In this new role, he’s responsible for making the intelligent nutrition company the top choice for distributors of animal nutrition solutions. “For the past few years, the Novus team has done an amazing job of refocusing the business and setting a trajectory for growth,” says Banaszak. “My goal is to enable that growth in markets where we work through channel partners, i.e. distributors.” Banaszak comes to Novus from Trouw Nutrition where he served as General Manager responsible for all aspects of the company’s export business across major markets in Asia Pacific from South Korea to New Zealand. Novus Senior Vice President and Chief Commercial Officer Ed Galo points out that Banaszak’s expertise in commercial leadership and business development made him a perfect fit for this new role. “Our long-term strategy involves both growing our direct business and significantly enhancing the way we work with distribution partners to optimize our market coverage across all important animal protein-producing regions of the world ensuring our customers have access to our intelligent nutrition solutions. Our global team and channel partners allow us to achieve maximum leverage of our current asset base, intellectual property, and application expertise and bring exceptional service to our customers,” Galo expresses. “Adam’s expertise in bringing people and plans together will be critical towards the realization of our goals.” Read more>> Novus appoints Adam Banaszak as new director Adam Banaszak Yield10 Bioscience, Inc., an agricultural bioscience company, signed a Memorandum of Understanding (MOU) and License Agreement with Nuseed Nutritional US Inc. (the seed technologies platform of Nufarm Limited), granting Nufarm a commercial license to certain omega-3 intellectual property assets, materials and know-how for producing oil in Camelina. Under the License Agreement, Nufarm will pay Yield10 up to USD $5 million. Nufarm and Yield10 have additionally agreed to immediately negotiate exclusively with each other for the sale of Yield10’s remaining assets to Nufarm. The asset sale will require an affirmative vote from the shareholders of Yield10, and a special meeting of shareholders will be convened to seek that vote following execution of the asset purchase agreement. Producing omega-3 fatty acids in Camelina may represent a way to enable a predictable, land-based supply of high-quality omega-3 oils to meet the growing global demand for eicosatetraenoic acid (EPA) and docosahexaenoic acid (DHA). Currently, the primary source of EPA and DHA remains ocean-caught fish, where omega-3 oil produced from anchovy harvest is the industry benchmark. Over the last few years, there has been increasing pressure on the supply of omega-3 oil due to over-fishing. “Yield10 Camelina assets and know-how in both omega 3 and bioenergy sectors have a unique fit with Nufarm’s Value Beyond Yield® and platform strategies,” said Greg Hunt, CEO and Group Executive of Nufarm. “While the program still requires further development time and investment before achieving revenue, it offers a broadened portfolio of solutions for our customers both at the farm-gate and with end-use customers.” Read more>> Yield10 Bioscience's omega-3 Camelina program transfers to Nufarm
RkJQdWJsaXNoZXIy MTUxNjkxNQ==